Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 8 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, Mar 2026, Apr 2026, Jun 2026, Jul 2026, Sep 2026 and Oct 2026.
- Largest single sale: $3.0M (107,537 shares) of Adaptive Biotechnologies Corp on Sep 16, 2026. Filing
- Last sale before this period: Mar 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Chief People Officer | Jun 26, 2019 | Oct 5, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 1, 2026, Adaptive Biotechnologies Corp: sold 26,792 shares for $758K, under a disclosed plan; 26,792 shares acquired by exercising options. 1 filing: 1
- Sep 16, 2026, Adaptive Biotechnologies Corp: sold 115,406 shares for $3.2M, under a disclosed plan; 105,560 shares acquired by exercising options. 1 filing: 1
- Jul 15, 2026, Adaptive Biotechnologies Corp: sold 105,762 shares for $2.4M, under a disclosed plan; 105,762 shares acquired by exercising options. 1 filing: 1
- Jul 2, 2026, Adaptive Biotechnologies Corp: sold 44,838 shares for $1.0M, under a disclosed plan; 37,863 shares acquired by exercising options. 1 filing: 1
- Jul 1, 2026, Adaptive Biotechnologies Corp: sold 51,004 shares for $1.1M, under a disclosed plan; 37,758 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.